C2 Dihydroceramide

C2 Dihydroceramide is a derivative of C2 Ceramide (HY-101180) . C2 Dihydroceramide enhances the ABCA1-mediated cholesterol efflux to apolipoprotein A-I (apoA-I) without causing cytotoxicity[1].

Product Specifications

CAS Number

[13031-64-6]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/c2-dihydroceramide.html

Purity

98.0

Smiles

CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O

Molecular Formula

C20H41NO3

Molecular Weight

343.54

Precautions

H302, H315, H319, H335

References & Citations

[1]Ghering AB, et al., Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein A-I. J Lipid Res. 2006 Dec;47 (12) :2781-8.